Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Certain gene variations might be linked to severe acne in women but not in men.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Finasteride-loaded ethosomes improve hair loss treatment by targeting pilosebaceous unit.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

VEGF and its receptor might cause hair loss.

Combination therapies work better than single treatments for atrophic acne scars.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.